Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000111461 | SCV001146735 | likely pathogenic | Phenylketonuria | 2019-08-11 | reviewed by expert panel | curation | The c.505C>T (p.Arg169Cys) PAH variant has been identified in at least 3 compound heterozygous probands with mild HPA to classic PKU, with at least 1 proband excluding BH4 deficiency (PMIDs: 28771436, 30050108, 30747360). It has been detected in trans with pathogenic variants Arg243Gln (ClinVar 591), Arg408Gln (ClinVar 577), and c.208_210del (ClinVar 102632). This variant occurs and a very low frequency of 0.00001194 in gnomAD. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_Strong, PM2, PP4_Moderate. |
Genome- |
RCV000111461 | SCV001810546 | likely pathogenic | Phenylketonuria | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000111461 | SCV002060148 | likely pathogenic | Phenylketonuria | 2021-11-08 | criteria provided, single submitter | clinical testing | NM_000277.1(PAH):c.505C>T(R169C) is a missense variant classified as likely pathogenic in the context of phenylalanine hydroxylase deficiency. Please note that the R169C mutation can be associated with any form of this disease. R169C has been observed in cases with relevant disease (PMID: 32668217, 30050108, 28982351, 28771436). Functional assessments of this variant are not available in the literature. R169C has been observed in population frequency databases (gnomAD: SAS 0.003%). In summary, NM_000277.1(PAH):c.505C>T(R169C) is a missense variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. |
Labcorp Genetics |
RCV000111461 | SCV002228976 | pathogenic | Phenylketonuria | 2024-09-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 169 of the PAH protein (p.Arg169Cys). This variant is present in population databases (rs281865440, gnomAD 0.003%). This missense change has been observed in individual(s) with PAH-related conditions (PMID: 28771436, 32668217; BIOPKU http://www.biopku.org). ClinVar contains an entry for this variant (Variation ID: 125436). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PAH protein function. This variant disrupts the p.Arg169 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10234516, 18299955, 21147011, 26666653, 28982351, 30459323). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000111461 | SCV004201358 | likely pathogenic | Phenylketonuria | 2024-03-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004719694 | SCV005325368 | pathogenic | not provided | 2024-02-27 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26503515, 29499199, 32668217, 30050108, 28771436, 29316886, 21147011, 36845377) |
Inserm U 954, |
RCV000111461 | SCV000143858 | probable-pathogenic | Phenylketonuria | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |